Duopharma earnings soar, plans bonus issue

TheStar Tue, May 04, 2021 08:00am - 2 years View Original


Duopharma said in a statement that financial performance had improved in the topline due to higher sales to the consumer healthcare sector during the reported quarter.

PETALING JAYA: Duopharma Biotech Bhd’s net profit rose about 30% year-on-year (y-o-y) to RM17.61mil in its first quarter ended March 31,2021.

Its bottom line rose was in tandem with the increase in revenue by almost 5% y-o-y to RM166.45mil.

The company said in a statement that financial performance had improved in the topline due to higher sales to the consumer healthcare sector during the reported quarter.

...

Full Article on TheStar

The content is a snapshot from Publisher. Refer to the original content for accurate info. Contact us for any changes.






Related Stocks

DPHARMA 1.180

Comments

Login to comment.